KRYS

268.54

0.54% -1.46

Handel nachbörslich: 268.28 -0.26 -0.10%

Krystal Biotech Inc (KRYS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt KRYS? Forum Prognose

Schlusskurs vom Vortag:

$270.00

Offen:

$270.01

24-Stunden-Volumen:

246.24K

Relative Volume:

0.85

Marktkapitalisierung:

$7.90B

Einnahmen:

$389.13M

Nettoeinkommen (Verlust:

$204.83M

KGV:

39.24

EPS:

6.8443

Netto-Cashflow:

$188.91M

1W Leistung:

+1.64%

1M Leistung:

+8.61%

6M Leistung:

+39.15%

1J Leistung:

+58.78%

1-Tages-Spanne:

$262.40

$271.05

1-Wochen-Bereich:

$252.30

$275.75

52-Wochen-Spanne:

$122.80

$298.30

Krystal Biotech Inc Stock (KRYS) Company Profile

Firmenname

Krystal Biotech Inc

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

(412) 586-5830

Adresse

2100 WHARTON STREET, PITTSBURGH, PA

Mitarbeiter

295

Twitter

@KrystalBiotech

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

KRYS's Discussions on Twitter

Compare KRYS vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KRYS Krystal Biotech Inc	268.54	7.95B	389.13M	204.83M	188.91M	6.8443
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-27	Eingeleitet	Wolfe Research	Peer Perform
2026-01-06	Hochstufung	Citigroup	Neutral → Buy
2025-03-05	Eingeleitet	Jefferies	Buy
2024-08-06	Herabstufung	Citigroup	Buy → Neutral
2023-11-20	Eingeleitet	Goldman	Buy
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-10-12	Eingeleitet	Citigroup	Buy
2023-09-07	Eingeleitet	Berenberg	Buy
2023-04-18	Eingeleitet	Stifel	Buy
2023-02-28	Hochstufung	Goldman	Neutral → Buy
2022-08-25	Herabstufung	Goldman	Buy → Neutral
2022-01-18	Eingeleitet	BofA Securities	Buy
2021-07-20	Hochstufung	Goldman	Neutral → Buy
2020-09-18	Eingeleitet	B. Riley FBR	Buy
2020-06-04	Eingeleitet	Evercore ISI	Outperform
2019-09-24	Eingeleitet	Goldman	Neutral
2019-08-06	Bestätigt	H.C. Wainwright	Buy
2019-06-24	Bestätigt	Chardan Capital Markets	Buy
2019-06-24	Bestätigt	H.C. Wainwright	Buy
2019-05-30	Eingeleitet	Guggenheim	Buy
2018-09-11	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten

Apr 14, 2026

Krystal Biotech Inc stock (US5012681064): Is its gene therapy pipeline strong enough to unlock new u - AD HOC NEWS

Apr 14, 2026

Apr 12, 2026

Book value per share of Krystal Biotech Inc Unsponsored BDR – BMFBOVESPA:K1YS34 - TradingView — Track All Markets

Apr 12, 2026

Apr 11, 2026

Total equity of Krystal Biotech Inc Unsponsored BDR – BMFBOVESPA:K1YS34 - TradingView — Track All Markets

Apr 11, 2026

Krystal Biotech (HAM:4KB) Cyclically Adjusted Price-to-FCF : (As of Apr. 11, 2026) - GuruFocus

Apr 11, 2026

Krystal Biotech (NASDAQ:KRYS) - intelligentinvestor.com.au

Apr 11, 2026

Apr 10, 2026

Price-Driven Insight from (KRYS) for Rule-Based Strategy - Stock Traders Daily

Apr 10, 2026

Krystal Biotech (HAM:4KB) Gross Property, Plant and Equipment : €161.7 Mil (As of Dec. 2025) - GuruFocus

Apr 10, 2026

Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 10, 2026

Krystal Biotech Inc Phase 1/2 Clinical Trial of KB103 Final Update Call Transcript - GuruFocus

Apr 10, 2026

Krystal Biotech Inc (HAM:4KB) Competitors 2026 - GuruFocus

Apr 10, 2026

Krystal Biotech (HAM:4KB) Net Income (Continuing Operations) : €177.8 Mil (TTM As of Dec. 2025) - GuruFocus

Apr 10, 2026

Krystal Biotech Inc (HAM:4KB)Valuation Measures & Financial Statistics - GuruFocus

Apr 10, 2026

Krystal Biotech Inc (HAM:4KB) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Apr 10, 2026

KRYS Technical Analysis | Trend, Signals & Chart Patterns | KRYSTAL BIOTECH INC (NASDAQ:KRYS) - ChartMill

Apr 10, 2026

Apr 08, 2026

BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $325 - Moomoo

Apr 08, 2026

Apr 07, 2026

Layoff Watch: Can Krystal Biotech Inc weather a recession2026 PreEarnings & Fast Gain Stock Trading Tips - baoquankhu1.vn

Apr 07, 2026

Could This Under-the-Radar Healthcare Stock Set You Up for Life? - AOL.com

Apr 07, 2026

Apr 04, 2026

KRYS | Krystal Biotech, Inc. Common Executive Compensation - Quiver Quantitative

Apr 04, 2026